Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201301089 Principal Investigator: Bartlett, Nancy
Title: A Randomized, Multicenter, Open-label, Phase 3 Study of the Bruton’s Tyrosine Kinase Inhibitor PCI-32765 versus Chlorambucil in Patients 65 Years or Older with Treatment-naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (PCYC-1115-CA)
Phase: III Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to see whether or not the study drug (PCI-32765) works and is safe in patients (65 years and older) with treatment naïve CLL/SLL compared to chlorambucil.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)